Page last updated: 2024-10-27

fleroxacin and Hansen Disease

fleroxacin has been researched along with Hansen Disease in 2 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Research Excerpts

ExcerptRelevanceReference
" In a dosage of 150 mg/kg administered daily, A-56619 is active and A-56620 is inactive against M."1.28Anti-Mycobacterium leprae activity of several quinolones studied in the mouse. ( Pattyn, SR, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pattyn, SR1
Tomioka, H1
Sato, K1
Saito, H1

Other Studies

2 other studies available for fleroxacin and Hansen Disease

ArticleYear
Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
    International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1991, Volume: 59, Issue:4

    Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Leprosy; Mice; Mycobact

1991
Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.
    Tubercle, 1991, Volume: 72, Issue:3

    Topics: Animals; Disease Models, Animal; Female; Fleroxacin; Leprosy; Mice; Mice, Inbred BALB C; Microbial S

1991